research use only
Cat.No.: S2714
Chemical Structure
| Related Targets | HDAC Caspase Proteasome MMP HCV Protease Cysteine Protease Tyrosinase HIV Protease DPP Serine Protease |
|---|---|
| Other Secretase Inhibitors | DAPT RO4929097 (RG-4733) Nirogacestat (PF-03084014) Dibenzazepine (YO-01027) MK-0752 Avagacestat (BMS-708163) Semagacestat (LY450139) MDL-28170 L-685,458 NGP 555 |
|
In vitro |
DMSO
: 95 mg/mL
(198.13 mM)
Ethanol : 13 mg/mL Water : Insoluble The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about LY411575 working concentrations for cell culture treatment
| Information | LY411575 is a potent γ-secretase and Notch inhibitor. It affects the Notch signaling pathway, and by blocking γ-secretase-mediated cleavage, it inhibits tumor proliferation and fibrosis, while promoting sensory neuronal generation and BCMA-targeted immune killing. |
|---|---|
| Primary Applications and Mechanism of Action |
| Molecular Weight | 479.48 | Formula | C26H23F2N3O4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 209984-57-6 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CC(C(=O)NC1C2=CC=CC=C2C3=CC=CC=C3N(C1=O)C)NC(=O)C(C4=CC(=CC(=C4)F)F)O | ||
Question 1:
Does this inhibitor act on beta-secretase?
Answer:
It has been reported to inhibit gamma-secretase, but currently, there is no publication reporting its inhibition on beta-secretase.